Evidence map›Paper›PMID 33244130›Full record

ArticleScientific reports2020

Redesigned reporter gene for improved proton exchange-based molecular MRI contrast.

Or Perlman, Hirotaka Ito, Assaf A Gilad, Michael T McMahon, E Antonio Chiocca, Hiroshi Nakashima, Christian T Farrar

Abstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Optimization of CEST MRI Reporter Protein Design Using Cation-Pi Networks.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Molecular imaging of stem cell therapies in ischemic stroke.European journal of nuclear medicine and molecular imaging · 2025
    Review
  8. Article
  9. Review
  10. A programmable genetic platform for engineering noninvasive biosensors.bioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Development of a Synthetic Biosensor for Chemical Exchange MRI UtilizingbioRxiv : the preprint server for biology · 2023
    Article
  19. Molecular MRI-Based Monitoring of Cancer Immunotherapy Treatment Response.International journal of molecular sciences · 2023
    Review
  20. Reporter Genes for Brain Imaging Using MRI, SPECT and PET.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Or PerlmanDepartment of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, 149 13th Street, Suite 2301, Charlestown, MA, 02129, USA.
Hirotaka ItoBrigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Assaf A GiladDepartment of Biomedical Engineering, Michigan State University, East Lansing, MI, USA.
Michael T McMahonF.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, USA.
E Antonio ChioccaBrigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Hiroshi NakashimaBrigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Christian T FarrarDepartment of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, 149 13th Street, Suite 2301, Charlestown, MA, 02129, USA. cfarrar@mgh.harvard.edu.

Funding

The Tumor Microenvironmental Barrier to Effective Viral OncolysisP01CA163205 · NCI · OHIO STATE UNIVERSITY · PI Balveen Kaur · 2013 to 2026
$26.0M
ULTRAHIGH FIELD TECHNOLOGY FOR FUNCTIONAL IMAGINGP41RR014075 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI BOAS, DAVID A · 1999 to 2011
$16.4M
Training/Dissemination-Resource for Molecular Imaging Agents in Precision MedicineP41EB024495 · NIBIB · UT SOUTHWESTERN MEDICAL CENTER · PI MARTIN G POMPER · 2017 to 2026
$11.8M
Brigham MRI Research Center (BMRC)G20RR031051 · NCRR · BRIGHAM AND WOMEN'S HOSPITAL · PI SELTZER, STEVEN E · 2010 to 2010
$6.1M
Clinically Translatable MRI Reporter Genes and Imaging Methods with Ultra-High Specificity and SensitivityR01EB031008 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI CHRISTIAN T FARRAR · 2021 to 2026
$4.0M
Oncolytic Virus Therapeutic Responses Occur from Changes in the Glioblastoma Immune MicroenvironmentR01NS110942 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI E. Antonio Chiocca, Hiroshi Nakashima · 2019 to 2026
$3.4M
Bioengineering a novel electromagnetic perspective gene as a tool for wireless control of excitable cellsR01NS098231 · NINDS · MICHIGAN STATE UNIVERSITY · PI GILAD, ASSAF A, PELLED, GALIT · 2017 to 2021
$2.6M
A CEST-MRI Reporter Gene for Image Guided Oncolytic VirotherapyR01CA203873 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI FARRAR, CHRISTIAN T · 2016 to 2020
$1.9M
Molecular Imaging for Detection of Synthetic Biology Circuits, Oscillators and Toggle Switches in Regenerative MedicineR01NS104306 · NINDS · MICHIGAN STATE UNIVERSITY · PI GILAD, ASSAF A · 2018 to 2021
$1.3M
7T Small Animal MRI ScannerS10OD010705 · OD · BRIGHAM AND WOMEN'S HOSPITAL · PI MUKUNDAN, SRINIVASAN · 2012 to 2012
$600k
Marie Curie 836752NCI NIH HHS P01 CA163205NCI NIH HHS R01 CA203873NCRR NIH HHS G20 RR031051NCRR NIH HHS P41 RR014075NIBIB NIH HHS P41 EB024495NIBIB NIH HHS R01 EB031008NIH HHS 1R01NS110942-01A1NIH HHS R01-CA203873NIH HHS R01NS098231NIH HHS S10 OD010705NINDS NIH HHS R01 NS098231NINDS NIH HHS R01 NS104306NINDS NIH HHS R01 NS110942
6 · The paper itself

Abstract

Reporter gene imaging allows for non-invasive monitoring of molecular processes in living cells, providing insights on the mechanisms underlying pathology and therapy. A lysine-rich protein (LRP) chemical exchange saturation transfer (CEST) MRI reporter gene has previously been developed and used to image tumor cells, cardiac viral gene transfer, and oncolytic virotherapy. However, the highly repetitive nature of the LRP reporter gene sequence leads to DNA recombination events and the expression of a range of truncated LRP protein fragments, thereby greatly limiting the CEST sensitivity. Here we report the use of a redesigned LRP reporter (rdLRP), aimed to provide excellent stability and CEST sensitivity. The rdLRP contains no DNA repeats or GC rich regions and 30% less positively charged amino-acids. RT-PCR of cell lysates transfected with rdLRP demonstrated a stable reporter gene with a single distinct band corresponding to full-length DNA. A distinct increase in CEST-MRI contrast was obtained in cell lysates of rdLRP transfected cells and in in vivo LRP expressing mouse brain tumors ([Formula: see text], n = 10).

Indexed as

Amino Acid SequenceAnimalsBrain NeoplasmsContrast MediaFemaleGenes, ReporterHEK293 CellsHumansMagnetic Resonance ImagingMiceMice, Inbred C57BLOncolytic VirotherapyProtonsContrast MediaProtons

Identifiers

PMID33244130
PMCPMC7692519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.